Company: BLNE
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001493152-25-018826
Chunk: 16

Company: Beeline Holdings, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 16
---
-year period from receiving a grace period for bid price deficiencies. Prior to the rule taking effect, such issuers would receive the general 180-day grace period to cure a bid price deficiency (plus the potential for an additional 180-day extension at the end of such initial grace period) to regain compliance with the minimum bid price requirement. Therefore, if the trading price of our common stock is below $1.00 for 30 consecutive trading days, before March 12, 2026, it would result in us receiving an immediate delist notice from Nasdaq without any 180-day grace period to regain compliance. Additionally, the new Nasdaq rule also provides that a reverse split cannot be used to cure a bid price deficiency if there have been one or more reverse splits within a two-year period and the combined ratios of such reverse splits are 250:1 or greater. These new rules will make it difficult to cure a bid price deficiency if the timing and circumstances are such that we cannot obtain a grace period or otherwise take the necessary actions and obtain the required approvals to effect a reverse split before a bid price deficiency occurs. If the Company’s common stock is delisted it would negatively impact the Company’s ability to raise capital and negatively impact our stockholders’ ability to trade their common stock.

| 10 |

<div align='center'>THE PURCHASE AGREEMENT</div>

Overview

On December 31, 2024, we entered into the Purchase Agreement with the Selling Stockholder, as amended and restated on March 7, 2025, pursuant to which the Selling Stockholder has agreed to purchase from us up to $10,000,000 of our common stock (subject to certain limitations). Also on December 31, 2024, we entered into a Registration Rights Agreement, as amended and restated on March 7, 2025, with the Selling Stockholder, pursuant to which we agreed to file a registration statement with the SEC to register the Selling Stockholder’s resale of shares of common stock issuable by us pursuant to the Purchase Agreement. In addition, pursuant to the Purchase Agreement, we issued C/M 573,925 shares of Series G Convertible Preferred Stock (“Series G”), (representing commitment shares valued at 1.5% of the original maximum ELOC amount), which were registered under the Form S-3. We initially used our Form S-3 under which the Selling Stockholder sold $7,500,000 of our common stock.

On September 8, 2025